I

ICLR

ICON PLC

145.21

-6.23-4.11%
After Hours: 145.21  0.00  0.00%16:36 05/01 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE142.61/151.44
TODAY RANGE135.00-147.49
VOL4.00M
MARKET CAP11.74B
52 WEEK RANGE133.28-347.72
AVG VOL (3M)1.29M
% TURNOVER4.95%
TURNOVER--
P/E (TTM)15.23
% RANGE8.25%
EPS(TTM)9.53
P/E(FORWARD)14.43
P/B1.231
BVPS117.92
DIVIDEND--
P/S1.416
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP11.66B
SHARES OUTSTANDING80.82M
NEXT EARNINGS07/22-07/28
FREE FLOAT80.32M
LOT SIZE1
EX-DIV DATE08/13/2008
Same Industry
Name/Symbol
Change%
Price

I

ICON PLC

ICLR

-4.11%
145.21

R

Regeneron Pharmaceuticals

REGN

-1.46%
590.00

E

Entero Therapeutics

ENTO

+4.14%
0.3548

B

BIONTECH

BNTX

-1.65%
102.43

U

United Therapeutics Corp.

UTHR

-3.05%
293.85

V

Vertex Pharmaceuticals Inc

VRTX

-2.09%
498.86

S

Siga Technologie

SIGA

-1.63%
5.43

M

Moderna

MRNA

-5.29%
27.03

C

Charles Riv Labs Intl Inc

CRL

-1.46%
116.89

M

Medpace Holdings

MEDP

-1.99%
302.25

T

Talphera Inc

TLPH

+4.41%
0.5116

C

China Biologic

CBPO

--
119.99

I

Iqvia Hldgs Inc

IQV

-2.56%
151.10

M

MOLECULAR PARTNERS AG

MOLN

-3.91%
3.75

P

PRA Health

PRAH

--
165.21

G

Gilead Sciences Inc

GILD

-3.09%
103.25

A

Arcturus Therape

ARCT

-2.42%
12.50

A

Aptevo Therapeutics Inc

APVO

-5.85%
0.4990

I

Incyte Corp

INCY

-1.01%
62.03

B

Biospecifics

BSTC

+0.15%
88.53

K

Kiniksa Pharmaceuticals International, plc

KNSA

+2.86%
27.74
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.